Wednesday, January 11, 2023: Life Sciences

The Food and Drug Administration (FDA) said its advisory panel will meet on February 15 to review Emergent Biosolutions Inc’s over-the-counter nasal spray to treat suspected opioid overdoses. Emergent is asking the FDA to approve for the prescription-free sale...

Wednesday, January 11, 2023: Mental Health

KFF released two new analyses examining how state Medicaid programs have utilized telehealth to increase access to behavioral health care during the pandemic and the strategies they are employing to address workforce shortages in behavioral health. The first analysis...